Current:Home > Contact-usAll in: Drugmakers say yes, they'll negotiate with Medicare on price, so reluctantly-Angel Dreamer Wealth Society D1 Reviews & Insights
All in: Drugmakers say yes, they'll negotiate with Medicare on price, so reluctantly
View Date:2024-12-24 22:10:30
For the first time, Medicare is beginning to negotiate the prices of prescription drugs. Despite a pack of industry lawsuits to keep the negotiations from happening, the drugmakers say they are coming to the bargaining table anyway.
It's been more than a month since the Biden administration announced the first ten drugs up for Medicare price negotiation, which a provision in the Inflation Reduction Act. The drugs included blockbuster blood thinners Xarelto and Eliquis, as well as drugs for arthritis, cancer, diabetes and heart failure.
Although more than a third of the companies that make drugs on the list have sued the federal government, all the companies have signed agreements saying they will negotiate.
The agreements were due Oct. 1.
"They're taking steps to participate in the negotiating program so we can give seniors the best possible deal," President Biden declared from the Oval Office in a video posted to X.com, formally known as Twitter.
Many of the drugmakers told NPR they had no choice. They could either agree to negotiate, pay steep fines or withdraw all their products from the Medicare and Medicaid markets.
"While we disagree on both legal and policy grounds with the IRA's new program, withdrawing all of the company's products from Medicare and Medicaid would have devastating consequences for the millions of Americans who rely on our innovative medicines, and it is not tenable for any manufacturer to abandon nearly half of the U.S. prescription drug market," a Merck spokesperson wrote in an email to NPR.
Merck makes Januvia, a drug that treats diabetes and was selected for price negotiation. The company has also brought one of the many lawsuits against the government to keep negotiation from happening.
Overall, the industry has argued that negotiating drug prices would stifle innovation.
"In light of the statutory deadline, we have signed the manufacturer agreement for the [Medicare] price setting program," an Amgen spokesperson wrote in an email to NPR. "We continue to believe the price setting scheme is unlawful and will impede medical progress for needed life-saving and life-enhancing therapies."
Amgen makes Enbrel, a drug on the negotiation list that treats rheumatoid arthritis and other autoimmune issues.
A Congressional Budget Office report found that drug pricing provisions in the Inflation Reduction Act would have only a modest impact on new drugs coming to market, and would save Medicare an estimated $237 billion over 10 years, with $98.5 billion of that coming from drug price negotiation.
On Sept. 29, a Trump-appointed judge declined to halt the negotiations in response to a lawsuit filed by the U.S. Chamber of Commerce, dealing another blow to the pharmaceutical industry.
The administration will tell companies its proposed prices for the first group of drugs on Feb. 1 of next year, and the drugmakers will have 30 days to accept or make a counter offer. The final negotiated prices will be announced in September 2024, and the new prices will go into effect in 2026.
Under the inflation Reduction Act, Medicare can negotiate the prices of more drugs each year, with up to 20 drugs eligible for negotiation 2029. To be eligible, they must meet certain criteria, including being on the market for a number of years and having no competition from generic or biosimilar products.
veryGood! (95622)
Related
- Walmart Planned to Remove Oven Before 19-Year-Old Employee's Death
- Mayorkas denounces Gov. Abbott's efforts to fortify border with razor wire, says migrants easily cutting barriers
- Jason Kelce, Lane Johnson run in and help Rey Mysterio grab WrestleMania 40 win
- Kim Kardashian, Gwyneth Paltrow and more stars laud microdermabrasion. What is it?
- 1 dead, 2 children injured in wrong-way crash; driver suspected of DWI: Reports
- Bachelor Alum Hannah Ann Sluss Reveals the Most Important Details of Her Wedding to Jake Funk
- Walmart shoppers: Deadline nears to get in on $45 million class action lawsuit settlement
- What Final Four games are today? Breaking down the NCAA Tournament semifinals of March Madness
- As CFP rankings punish SEC teams, do we smell bias against this proud and mighty league?
- Ahead of $1.23 billion jackpot drawing, which states have the most lottery winners?
Ranking
- Louisville officials mourn victims of 'unthinkable' plant explosion amid investigation
- Man arrested for setting fire at Sen. Bernie Sanders’ office; motive remains unclear
- Don Lemon Marries Tim Malone in Star-Studded NYC Wedding
- Following program cuts, new West Virginia University student union says fight is not over
- What Happened to Kevin Costner’s Yellowstone Character? John Dutton’s Fate Revealed
- Will the 2024 total solar eclipse hit near you? A detailed look at the path of totality.
- Kamilla Cardoso formidable and immovable force for South Carolina, even when injured
- Powerball lottery drawing delayed
Recommendation
-
Former NFL coach Jack Del Rio charged with operating vehicle while intoxicated
-
Meta to adjust AI policies on content after board said they were incoherent and confusing
-
South Carolina could finish season undefeated. What other teams have pulled off the feat?
-
Attn: Foodies! Shop Sur La Table’s Epic Warehouse Sale, Including 65% off Le Creuset, Staub & More
-
‘COP Fatigue’: Experts Warn That Size and Spectacle of Global Climate Summit Is Hindering Progress
-
NXT Stand and Deliver 2024 results: Matches, highlights from Philadelphia
-
Walmart shoppers: Deadline nears to get in on $45 million class action lawsuit settlement
-
The Challenge’s Adam Larson and Flora Alekseyeva Reveal Why They Came Back After Two Decades Away